Myricx Bio has secured £90m ($114m) in its Series A financing round to propel its NMTi-ADC therapeutics into the clinical ...

China's NMPA approved Antengene’s new indication of XPOVIO for adults with relapsed or refractory diffuse large B-cell ...

Ascentage Pharma has obtained approval for its new BCR-ABL1 TKI, olverembatinib, in Macau for haematological malignancy ...

GSK and MMV have announced the launch of tafenoquine to prevent the relapse of P. vivax malaria in Brazil and Thailand.

Fucaso, a BCMA CAR T-cell therapy, is co-developed by Innovent and IASO Bio and was approved to treat multiple myeloma in ...

The UK life science industry is crossing its fingers as a Labour government takes the reigns following 14 years of ...

Approval is based on positive data from the Phase III FLAURA2 trial where Tagrisso plus chemotherapy showed PFS of 24.4 ...

As Finland administers the world’s first avian influenza vaccine for humans, the WHO says H5N1 has “pandemic potential”.

As the UK transitions into a Labour party government, the pharma industry urges for boosted investment and talent attraction.

Roche has received approval from the US FDA for the Vabysmo prefilled syringe (PFS) for treating three leading causes of ...

Whilst Regeneron and Sanofi secured approval in Europe for COPD, the FDA has delayed Dupixent’s application review for the ...

Boehringer Ingelheim and OSE Immunotherapeutics have announced the progression of a SIRPα inhibitor antibody, BI 770371, to ...